Financial Snapshot

Revenue
$0.00
TTM
Gross Margin
Net Earnings
-$257.6M
TTM
Current Assets
Q2 2024
Current Liabilities
Q2 2024
Current Ratio
2662.99%
Q2 2024
Total Assets
Q2 2024
Total Liabilities
Q2 2024
Book Value
$775.2M
Q2 2024
Cash
Q2 2024
P/E
-13.38
Sep 18, 2024 EST
Free Cash Flow
-$220.3M
TTM

Revenues

Revenues

Loading...

Revenue YoY Change

Loading...

Revenues

Concept 2023 2022 2021 2020 2019 2018
Revenue $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change

Expenses

Cost Of Revenues

Loading...

Gross Profit

Loading...

Gross Profit Margin

Loading...

Gross Profit

Concept 2023 2022 2021 2020 2019 2018
Revenue $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Cost Of Revenue
Gross Profit
Gross Profit Margin

Selling, General & Admin Expense

Loading...

Research & Development

Loading...

Depreciation, Depletion & Amortization

Loading...

SGA Expense to Gross Profit Ratio

Loading...

R&D To Gross Profit Ratio

Loading...

DDA To Gross Profit Ratio

Loading...

Operating Expenses Total

Loading...

Operating Profits/Loss

Loading...

Operational Expenses

Concept 2023 2022 2021 2020 2019 2018
Selling, General & Admin $31.40M $28.20M $28.72M $13.45M $2.790M $520.0K
YoY Change 11.34% -1.79% 113.51% 382.08% 436.54%
% of Gross Profit
Research & Development $210.8M $142.8M $121.3M $45.20M $11.04M $4.280M
YoY Change 47.63% 17.68% 168.38% 309.42% 157.94%
% of Gross Profit
Depreciation & Amortization $1.700M $1.700M $1.100M $700.0K $271.0K $20.00K
YoY Change 0.0% 54.55% 57.14% 158.3% 1255.0%
% of Gross Profit
Operating Expenses $242.2M $171.0M $150.0M $58.65M $13.83M $4.800M
YoY Change 41.65% 13.96% 155.81% 324.18% 188.04%
Operating Profit -$242.2M -$171.0M -$150.0M -$58.65M -$13.83M
YoY Change 41.65% 13.96% 155.81% 324.18%

Interest Expenses

Loading...

Interest Expenses To Operating Income %

Loading...

Other Expense/Income

Loading...

Interest & Other Expense/Income

Concept 2023 2022 2021 2020 2019 2018
Interest Expense $7.641M $2.917M $742.0K -$340.0K $290.0K $10.00K
YoY Change 161.95% 293.13% -318.24% -217.24% 2800.0%
% of Operating Profit
Other Income/Expense, Net $6.225M $2.863M $734.0K -$790.0K -$1.033M -$20.00K
YoY Change 117.43% 290.05% -192.91% -23.52% 5065.0%

Income/Loss

Pretax Income

Loading...

Income Tax

Loading...

Net Profits/Loss

Loading...

Pretax Income YoY Change

Loading...

Income Tax Rate

Loading...

Net Profits/Loss YoY Change

Loading...

Basic EPS

Loading...

Net Income To Revenue Ratio

Loading...

Pretax & Net Income

Concept 2023 2022 2021 2020 2019 2018
Pretax Income -$235.9M -$168.1M -$149.3M -$59.44M -$14.86M -$4.810M
YoY Change 40.36% 12.6% 151.16% 300.0% 208.94%
Income Tax
% Of Pretax Income
Net Earnings -$235.9M -$168.1M -$149.3M -$59.44M -$14.86M -$4.810M
YoY Change 40.36% 12.6% 151.18% 300.01% 208.92%
Net Earnings / Revenue
Basic Earnings Per Share -$3.95 -$3.23 -$2.93
Diluted Earnings Per Share -$3.95 -$3.23 -$2.933M -$1.319M -$340.9K -$110.3K

Assets & Liabilities

Cash & Short-Term Investments

Loading...

Cash & Equivalents

Loading...

Cash To Operating Expenses Ratio

Loading...

Inventory

Loading...

Receivables

Loading...

Total Short-Term Assets

Loading...

Property, Plant And Equipment

Loading...

Long-Term Investments

Loading...

Total Long-Term Assets

Loading...

Total Assets

Loading...

Net Income To Total Assets Percentage

Loading...

Accounts Payable

Loading...

Short-Term Debt

Loading...

Long Term Debt Due

Loading...

Total Short-Term Liabilities

Loading...

Long-Term Debt

Loading...

Other Long-Term Liabilities

Loading...

Total Long-Term Liabilities

Loading...

Total Liabilities

Loading...

Short-Term To Long-Term Debt Ratio

Loading...

Short-Term Assets To Debt Ratio

Loading...

Long-Term Debt To Net Income Ratio

Loading...

Assets & Liabilities

Concept 2023 2022 2021 2020 2019 2018
Cash & Short-Term Investments $123.1M $256.0M $376.6M $345.3M $14.60M $8.100M
YoY Change -51.92% -32.01% 9.06% 2265.07% 80.25%
Cash & Equivalents $121.6M $172.1M $200.8M $300.9M $14.60M $8.100M
Short-Term Investments $1.474M $83.87M $175.7M $44.50M
Other Short-Term Assets $6.275M $9.582M $5.821M $3.800M $100.0K $0.00
YoY Change -34.51% 64.61% 53.18% 3700.0%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $129.4M $265.6M $382.4M $349.1M $14.80M $8.200M
YoY Change -51.29% -30.54% 9.54% 2258.78% 80.49%
Property, Plant & Equipment $33.39M $38.41M $40.96M $1.900M $1.500M $100.0K
YoY Change -13.07% -6.22% 2055.79% 26.67% 1400.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $2.315M $2.319M $2.311M $2.300M $200.0K $0.00
YoY Change -0.17% 0.35% 0.48% 1050.0%
Total Long-Term Assets $35.71M $40.73M $43.27M $4.200M $1.600M $100.0K
YoY Change -12.33% -5.87% 930.26% 162.5% 1500.0%
Total Assets $165.1M $306.3M $425.7M $353.3M $16.40M $8.300M
YoY Change
Accounts Payable $22.94M $5.259M $4.031M $3.400M $1.300M $500.0K
YoY Change 336.13% 30.46% 18.56% 161.54% 160.0%
Accrued Expenses $28.16M $22.83M $24.69M $7.500M $1.100M $200.0K
YoY Change 23.35% -7.54% 229.23% 581.82% 450.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $51.10M $28.09M $28.72M $11.00M $2.400M $700.0K
YoY Change 81.91% -2.21% 161.12% 358.33% 242.86%
Long-Term Debt $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $22.70M $25.87M $28.74M $0.00 $0.00 $3.400M
YoY Change -12.28% -9.99% -100.0%
Total Long-Term Liabilities $22.70M $25.87M $28.74M $0.00 $0.00 $3.400M
YoY Change -12.28% -9.99% -100.0%
Total Liabilities $73.79M $53.96M $57.47M $11.00M $2.400M $4.100M
YoY Change 36.75% -6.1% 422.42% 358.33% -41.46%

Ownership

Basic Shares Outstanding

Loading...

Diluted Shares Outstanding

Loading...

Preferred Stock

Loading...

Treasury Stock Shares

Loading...

Stock Issuance & Repurchase

Loading...

Ownership Data

Concept 2023 2022 2021 2020 2019 2018
Basic Shares Outstanding
Diluted Shares Outstanding
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Loading...

Book Value

Loading...

Free Cash Flow

Loading...

Free Cash Flow YoY

Loading...

Dividends

Dividends

Loading...

Stock Price

Loading...
Market Cap: $3.4478 Billion

About Dyne Therapeutics Inc

Dyne Therapeutics, Inc. engages in developing innovative life-transforming therapies for genetically driven muscle diseases. The company is headquartered in Waltham, Massachusetts and currently employs 143 full-time employees. The company went IPO on 2020-09-17. The company is focused on advancing life-transforming therapeutics for people living with genetically driven diseases. The company is utilizing its FORCE platform to overcome the limitations of muscle tissue delivery and oligonucleotide therapeutics for muscle diseases. Its FORCE platform therapeutics consist of an oligonucleotide payload that is designed to target the genetic basis of the disease. Using its FORCE platform, it is assembling a portfolio of muscle disease therapeutics, including its lead programs in myotonic dystrophy type 1 (DM1), Duchenne muscular dystrophy (DMD), and facioscapulohumeral dystrophy (FSHD). Its therapeutics consist of three components: a Fab, a clinically validated linker, and an oligonucleotide payload that it attaches to its Fab using the linker. The company also plans to expand its portfolio through development efforts focused on rare skeletal muscle diseases, as well as cardiac and metabolic muscle diseases.

Industry: Pharmaceutical Preparations Peers: Alector Inc Allovir Inc AnaptysBio Inc Anavex Life Sciences Corp Coherus BioSciences Inc RAPT Therapeutics Inc Northwest Biotherapeutics Inc Sorrento Therapeutics Inc Seres Therapeutics Inc